Stock listing
KRX:115180 Qurient Co., Ltd. (큐리언트) 주가
Follow Qurient Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:115180
₩13,180 KRW +150 (+1.2%)
Close on Nov 20, 2026
- Day range
- ₩13,060 – ₩14,500 KRWNov 20, 2026
- Volume
- 449,311 sharesNov 20, 2026
- Market cap
- ₩519.7B KRWAt the close on Nov 20, 2026 · price × 39.43M shares outstanding
- 52-week range
- ₩12,890 – ₩62,900 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩3.63B KRWMedian day 138,545 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:115180 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩13,180 | +150 | +1.2% | ₩13,880 | ₩14,500 | ₩13,060 | 449,311 | |
| ₩13,030 | -120 | -0.9% | ₩13,160 | ₩13,540 | ₩12,890 | 184,638 | |
| ₩13,150 | -270 | -2.0% | ₩13,300 | ₩13,550 | ₩13,010 | 128,104 | |
| ₩13,420 | -1,090 | -7.5% | ₩14,500 | ₩14,720 | ₩13,350 | 146,419 | |
| ₩14,510 | -1,930 | -11.7% | ₩16,200 | ₩16,800 | ₩14,450 | 246,036 | |
| ₩16,440 | +620 | +3.9% | ₩15,630 | ₩16,860 | ₩15,330 | 185,679 | |
| ₩15,820 | +30 | +0.2% | ₩15,580 | ₩16,110 | ₩15,420 | 211,552 | |
| ₩15,790 | +970 | +6.5% | ₩15,730 | ₩15,980 | ₩14,880 | 110,128 | |
| ₩14,820 | -490 | -3.2% | ₩15,130 | ₩15,600 | ₩13,950 | 118,909 | |
| ₩15,310 | -1,680 | -9.9% | ₩15,300 | ₩16,130 | ₩15,120 | 172,906 | |
| ₩16,990 | +750 | +4.6% | ₩16,600 | ₩19,220 | ₩16,600 | 180,181 | |
| ₩16,240 | +400 | +2.5% | ₩15,870 | ₩16,540 | ₩15,100 | 140,426 | |
| ₩15,840 | -970 | -5.8% | ₩16,700 | ₩16,700 | ₩15,400 | 112,147 | |
| ₩16,810 | +220 | +1.3% | ₩16,650 | ₩17,130 | ₩15,900 | 129,860 | |
| ₩16,590 | -1,240 | -7.0% | ₩17,410 | ₩17,640 | ₩16,400 | 78,238 | |
| ₩17,830 | -140 | -0.8% | ₩17,750 | ₩18,190 | ₩17,300 | 97,136 | |
| ₩17,970 | -470 | -2.5% | ₩18,530 | ₩18,530 | ₩17,000 | 149,001 | |
| ₩18,440 | -630 | -3.3% | ₩19,260 | ₩19,590 | ₩18,000 | 136,664 | |
| ₩19,070 | -400 | -2.1% | ₩19,620 | ₩20,250 | ₩18,200 | 95,773 | |
| ₩19,470 | -730 | -3.6% | ₩19,710 | ₩20,150 | ₩19,220 | 61,192 | |
| ₩20,200 | -1,450 | -6.7% | ₩21,900 | ₩21,900 | ₩19,940 | 119,213 | |
| ₩21,650 | +1,650 | +8.3% | ₩20,000 | ₩22,350 | ₩19,860 | 171,392 | |
| ₩20,000 | +700 | +3.6% | ₩19,550 | ₩20,000 | ₩18,720 | 112,392 | |
| ₩19,300 | -2,200 | -10.2% | ₩19,950 | ₩20,400 | ₩18,950 | 125,255 | |
| ₩21,500 | +700 | +3.4% | ₩20,600 | ₩22,150 | ₩19,520 | 136,583 | |
| ₩20,800 | -600 | -2.8% | ₩21,300 | ₩21,650 | ₩20,150 | 160,419 | |
| ₩21,400 | +1,800 | +9.2% | ₩20,600 | ₩22,300 | ₩19,800 | 346,653 | |
| ₩19,600 | -2,250 | -10.3% | ₩22,700 | ₩22,700 | ₩19,000 | 484,493 | |
| ₩21,850 | -500 | -2.2% | ₩22,350 | ₩23,350 | ₩21,550 | 113,428 | |
| ₩22,350 | -1,850 | -7.6% | ₩23,450 | ₩24,000 | ₩20,800 | 203,122 | |
| ₩24,200 | -800 | -3.2% | ₩24,600 | ₩25,500 | ₩23,850 | 72,412 | |
| ₩25,000 | +250 | +1.0% | ₩24,900 | ₩25,800 | ₩24,050 | 115,347 | |
| ₩24,750 | +100 | +0.4% | ₩25,050 | ₩25,200 | ₩24,150 | 59,268 | |
| ₩24,650 | +2,650 | +12.0% | ₩22,250 | ₩25,150 | ₩22,250 | 216,411 | |
| ₩22,000 | +500 | +2.3% | ₩21,500 | ₩22,600 | ₩21,300 | 39,583 | |
| ₩21,500 | -1,050 | -4.7% | ₩22,800 | ₩22,850 | ₩21,350 | 72,547 | |
| ₩22,550 | -50 | -0.2% | ₩23,050 | ₩23,350 | ₩22,400 | 52,973 | |
| ₩22,600 | +100 | +0.4% | ₩22,650 | ₩23,000 | ₩22,350 | 47,090 | |
| ₩22,500 | +300 | +1.4% | ₩22,200 | ₩22,850 | ₩21,700 | 90,826 | |
| ₩22,200 | +800 | +3.7% | ₩22,100 | ₩22,700 | ₩21,600 | 59,341 | |
| ₩21,400 | -1,000 | -4.5% | ₩22,400 | ₩22,600 | ₩21,400 | 87,269 | |
| ₩22,400 | +450 | +2.1% | ₩22,000 | ₩23,600 | ₩21,500 | 118,824 | |
| ₩21,950 | +100 | +0.5% | ₩21,500 | ₩22,150 | ₩21,050 | 39,269 | |
| ₩21,850 | -250 | -1.1% | ₩21,800 | ₩23,000 | ₩21,350 | 78,114 | |
| ₩22,100 | +300 | +1.4% | ₩21,150 | ₩22,700 | ₩21,150 | 101,435 | |
| ₩21,800 | +50 | +0.2% | ₩21,050 | ₩22,050 | ₩20,750 | 91,239 | |
| ₩21,750 | -750 | -3.3% | ₩22,050 | ₩22,200 | ₩20,900 | 144,637 | |
| ₩22,500 | -450 | -2.0% | ₩22,500 | ₩23,000 | ₩21,550 | 175,430 | |
| ₩22,950 | -2,800 | -10.9% | ₩25,400 | ₩25,600 | ₩22,650 | 246,754 | |
| ₩25,750 | +2,700 | +11.7% | ₩22,700 | ₩26,250 | ₩22,350 | 354,426 | |
| ₩23,050 | +3,400 | +17.3% | ₩19,960 | ₩23,300 | ₩18,830 | 658,970 | |
| ₩19,650 | -850 | -4.1% | ₩20,800 | ₩21,150 | ₩19,540 | 284,229 | |
| ₩20,500 | -850 | -4.0% | ₩20,700 | ₩21,800 | ₩20,500 | 196,556 | |
| ₩21,350 | +800 | +3.9% | ₩20,350 | ₩21,700 | ₩20,150 | 180,418 | |
| ₩20,550 | +250 | +1.2% | ₩19,400 | ₩20,650 | ₩18,170 | 219,337 | |
| ₩20,300 | -2,000 | -9.0% | ₩21,700 | ₩21,700 | ₩19,680 | 389,292 | |
| ₩22,300 | -3,350 | -13.1% | ₩25,350 | ₩25,450 | ₩20,450 | 649,613 | |
| ₩25,650 | +600 | +2.4% | ₩24,900 | ₩26,650 | ₩24,900 | 221,444 | |
| ₩25,050 | -1,300 | -4.9% | ₩25,700 | ₩26,000 | ₩23,500 | 175,936 | |
| ₩26,350 | +1,550 | +6.3% | ₩25,450 | ₩27,950 | ₩25,250 | 380,299 | |
| ₩24,800 | -1,250 | -4.8% | ₩25,200 | ₩26,050 | ₩23,700 | 161,311 | |
| ₩26,050 | +800 | +3.2% | ₩26,900 | ₩27,500 | ₩24,900 | 120,511 |
Splits
2 splits since 2023 · KRX:115180 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 13-for-10 | Split | |
| 95-for-82 | Split |
- Ticker
- KRX:115180
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Latest news
Qurient Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in all · newest Sep 25, 2025 · oldest 2025
Valuation
EV/sales 70.5× against a median of 32.5×: the highest of 5 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩498.2B KRW
- P/E
- Loss
- EV/sales
- 70.5×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 30.2×
- Gross margin
- 11.5%
- Operating margin
- −520.4%
- Net margin
- −543.0%
- Debt to equity
- 0.8×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Qurient Co., Ltd. · KRX:115180 | US$388.5M | US$372.4M | n/a | 70.5× | n/a | 30.2× | −543.0% | 0.8× | n/a |
| Candel Therapeutics, Inc. · NASDAQ:CADL | US$395.4M | US$193.8M | n/a | n/a | n/a | 3.0× | n/a | 0.0× | 2.03 |
| Ever Supreme Bio Technology Co., Ltd. · TPEX:6712 | US$394.8M | US$362.8M | 27.5× | 11.1× | 23.9× | 4.6× | 43.8% | 0.0× | n/a |
| Mezzion Pharma Co., Ltd. · KRX:140410 | US$391.0M | US$360.8M | n/a | 57.3× | n/a | 13.4× | −325.0% | 0.0× | n/a |
| Avalo Therapeutics, Inc. · NASDAQ:AVTX | US$390.9M | −US$1.93M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 1.25 |
| Beijing Luzhu Biotechnology Co., Ltd. Class H · HKEX:2480 | US$388.2M | US$369.1M | n/a | n/a | n/a | 4.3× | n/a | 0.4× | n/a |
| Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H · HKEX:3378 | US$387.5M | US$316.0M | n/a | n/a | n/a | 4.1× | n/a | 0.1× | n/a |
| Opus Genetics, Inc. · NASDAQ:IRD | US$385.7M | US$332.3M | n/a | 42.0× | n/a | 10.0× | n/a | 0.9× | 1.01 |
| Eupraxia Pharmaceuticals, Inc. · TSX:EPRX | US$384.3M | US$252.7M | n/a | n/a | n/a | 2.9× | n/a | 0.0× | 1.53 |
| Hinova Pharmaceuticals, Inc. Class A · SSE:688302 | US$381.1M | US$285.9M | n/a | 23.0× | n/a | 2.6× | −167.3% | 0.1× | n/a |
| Rezolute, Inc. · NASDAQ:RZLT | US$379.2M | US$289.9M | n/a | n/a | n/a | 4.4× | n/a | 0.0× | 1.28 |
| Median of the others | US$387.9M | US$303.0M | 27.5× | 32.5× | 23.9× | 4.2× | −167.3% | 0.0× | 1.28 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2025 | May 12, 2025 · After close | +0.9% |
| Q3 2024 | Nov 7, 2024 · After close | −2.4% |
| Quarter to Dec 31, 2022 | Mar 17, 2023 · After close | +0.7% |
| Quarter to Sep 30, 2022 | Nov 14, 2022 · After close | −5.3% |
| Quarter to Jun 30, 2022 | Aug 16, 2022 · Before open | |
| Quarter to Mar 31, 2022 | May 16, 2022 · After close | |
| Quarter to Sep 30, 2021 | Nov 15, 2021 · After close | |
| Quarter to Jun 30, 2021 | Aug 17, 2021 · After close | |
| Q1 2021 | May 14, 2021 · After close |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.98B | 9.18B | 9.03B | 8.47B | 4.89B | 0 | 0 | 0 | ||
| Cost of revenue | 6.05B | 7.83B | 7.27B | 6.69B | 4.00B | 0 | 0 | 0 | ||
| Gross profit | 929.9M | 1.35B | 1.76B | 1.78B | 885.2M | 0 | 0 | 0 | ||
| Research and development | 21.5B | 20.4B | 16.8B | 19.7B | 16.4B | 12.5B | 7.58B | 6.05B | ||
| Selling, general and administrative | 3.69B | 7.53B | 7.39B | 8.85B | 3.73B | 6.78B | 5.09B | 4.04B | 5.05B | 4.91B |
| Operating income | -29.8B | -27.5B | -23.2B | -27.5B | -24.2B | -21.0B | -23.2B | -16.7B | -12.7B | -11.1B |
| Depreciation and amortization | 961.2M | 579.8M | 539.6M | 444.3M | 665.2M | 540.6M | 444.6M | 58.3M | 69.6M | 100.6M |
| EBITDA | -28.8B | -26.9B | -22.7B | -27.0B | -23.6B | -20.5B | -22.7B | -16.6B | -12.7B | -11.0B |
| Interest expense | 310.5M | 27.8M | 18.6M | 26.0M | 36.6M | 0 | 0 | 0 | 0 | 0 |
| Income before tax | -31.3B | -24.5B | -22.2B | -27.1B | -23.9B | -20.8B | -22.7B | -16.4B | -12.2B | -10.5B |
| Income tax | -13.2M | 13.2M | 0 | |||||||
| Net income | -30.1B | -23.6B | -21.1B | -25.5B | -22.8B | -20.5B | -22.7B | -16.4B | -12.2B | -10.5B |
| Earnings per share, basic | -808.20 | -729.92 | -794.91 | -1,389.37 | -1,707.78 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21.0B | 1.85B | 1.94B | 20.6B | 18.5B | 570 | 120 | -810 | 300 | 1.42B |
| Short-term investments | 29.0B | 33.1B | 7.87B | 12.5B | 33.4B | 34.9B | 9.89B | 2.00B | ||
| Receivables | 536.8M | 1.09B | 1.13B | 645.3M | 1.63B | 268.0K | 29.7M | 120.2M | 28.5M | |
| Inventory | 46.3M | 97.0M | 170.5M | 146.7M | 153.7M | |||||
| Current assets | 51.6B | 50.6B | 44.4B | 34.2B | 53.9B | 58.8B | 18.9B | 42.4B | 15.2B | 25.8B |
| Property, plant and equipment | 915.2M | 368.7M | 798.7M | 1.02B | 838.8M | 64.0M | 104.7M | 171.6M | ||
| Goodwill | 666.7M | 934.7M | 934.7M | 934.7M | 934.7M | |||||
| Total assets | 62.0B | 65.6B | 52.5B | 38.4B | 57.6B | 60.8B | 20.5B | 43.2B | 15.7B | 26.2B |
| Accounts payable | 336.4M | 113.2M | 56.8M | 396.6M | 285.7M | |||||
| Current liabilities | 3.90B | 5.01B | 2.33B | 2.95B | 2.76B | 2.70B | 2.49B | 3.73B | 1.13B | 1.79B |
| Long-term debt | 12.3B | 0 | 0 | 0 | ||||||
| Total debt | 755.8M | 460.9M | ||||||||
| Total liabilities | 22.8B | 7.97B | 5.88B | 3.28B | 3.55B | 4.24B | 3.14B | 3.79B | 1.15B | 1.89B |
| Shareholders' equity | 34.0B | 57.6B | 46.6B | 31.0B | 51.6B | 56.6B | 17.4B | 39.4B | 14.5B | 24.3B |
| Shares outstanding | 37.2M | 32.3M | 26.6M | 18.3M | 13.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -28.7B | -23.3B | -22.0B | -25.0B | -24.4B | -19.8B | -24.0B | -13.8B | -12.6B | -9.90B |
| Capital spending | -3.70B | -83.7M | -101.1M | -518.6M | -259.8M | -10.7M | -12.5M | -432.1M | -72.8M | -50.3M |
| Free cash flow | -32.4B | -23.4B | -22.1B | -25.5B | -24.6B | -19.9B | -24.0B | -14.2B | -12.7B | -9.95B |
| Cash from investing | -24.1B | 4.15B | 21.0B | -39.1B | 20.4B | -25.1B | -7.54B | -1.58B | ||
| Cash from financing | 26.8B | 31.5B | 6.27B | 59.9B | -6.39M | 41.2B | 1.54B | 31.8B | ||
| Dividends paid | -69.4M | -70.0M | ||||||||
| Share buybacks | 21.4B | 28.7B | 6.77B | 60.2B | 318.9M | 41.2B | 1.54B | 31.8B | ||
| Change in cash | 6.02B | -19.9B | 14.3B | 2.13B | 13.8B | 906.4M | -3.62B | 2.31B | -18.6B | 20.4B |
Cap table
Built by 6ix from Qurient Co., Ltd.’s releases
- Common shares
- 39,433,948
- Fully diluted
- 39,433,948
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 39,433,948 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 39,433,948 |
Log in to ask 6ix AI your own questions about Qurient Co., Ltd.